Efficiency and safety of inhalative sedation with sevoflurane in comparison to an intravenous sedation concept with propofol in intensive care patients: study protocol for a randomized controlled trial

Jens Soukup, Antje Selle, Andreas Wienke, Jörg Steighardt, Nana-Maria Wagner, Patrick Kellner, Jens Soukup, Antje Selle, Andreas Wienke, Jörg Steighardt, Nana-Maria Wagner, Patrick Kellner

Abstract

Background: State of the art sedation concepts on intensive care units (ICU) favor propofol for a time period of up to 72 h and midazolam for long-term sedation. However, intravenous sedation is associated with complications such as development of tolerance, insufficient sedation quality, gastrointestinal paralysis, and withdrawal symptoms including cognitive deficits. Therefore, we aimed to investigate whether sevoflurane as a volatile anesthetic technically implemented by the anesthetic-conserving device (ACD) may provide advantages regarding 'weaning time', efficiency, and patient's safety when compared to standard intravenous sedation employing propofol.

Method/design: This currently ongoing trial is designed as a two-armed, monocentric, randomized prospective phase II study including intubated intensive care patients with an expected necessity for sedation exceeding 48 h. Patients are randomly assigned to either receive intravenous sedation with propofol or sevoflurane employing the ACD. Primary endpoint is the comparison of the 'weaning time' defined as the time required from discontinuation of the sedating agent until sufficient spontaneous breathing occurs. Moreover, sedation depth evaluated by Richmond Agitation Sedation Scale and parameters of patient's safety (that is, vital signs, laboratory monitoring of organ function) as well as the duration of mechanical ventilation and overall stay on the ICU are analyzed and compared. An intention-to-treat analysis will be carried out with all patients for whom it will be possible to define a wake-up time. In addition, a per-protocol analysis is envisaged. Completion of patient recruitment is expected by the end of 2012.

Discussion: This clinical study is designed to evaluate the impact of sevoflurane during long-term sedation of critically ill patients on 'weaning time', efficiency, and patient's safety compared to the standard intravenous sedation concept employing propofol.

Trial registration: EudraCT2007-006087-30; ISRCTN90609144.

Figures

Figure 1
Figure 1
Flowchart of the study set-up.
Figure 2
Figure 2
The anesthetic-conserving device (AnaConDa®) in the clinical set-up.

References

    1. Martin J, Heymann A, Bäsell K, Baron R, Biniek R, Bürkle H, Dall P, Dictus C, Eggers V, Eichler I, Engelmann L, Garten L, Hartl W, Haase U, Huth R, Kessler P, Kleinschmidt S, Koppert W, Kretz FJ, Laubenthal H, Marggraf G, Meiser A, Neugebauer E, Neuhaus U, Putensen C, Quintel M, Reske A, Roth B, Scholz J, Schröder S. et al.Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care--short version. Ger Med Sci. 2010;8:Doc02.
    1. Badeva B, Iskrenova I, Panchev P, Gerov I, Nemtsova D, Radichkova V, Petrov P, Gerzilova L, Aluan K. Prolonged propofol (Diprivan) infusion for sedation in the critically ill. Khirurgiia. 1996;49:28–30.
    1. Darrouj J, Karma L, Arora R. Cardiovascular manifestations of sedatives and analgesics in the critical care unit. Am J Ther. 2009;16:339–353. doi: 10.1097/01.pap.0000249925.76324.47.
    1. Kelly DF. Propofol-infusion syndrome. J Neurosurg. 2001;95:925–926. doi: 10.3171/jns.2001.95.6.0925.
    1. Ostermann ME, Keenan SP, Seiferling RA, Sibbald WJ. Sedation in the intensive care unit: a systematic trial. JAMA. 2000;Suppl 11:1451–1459.
    1. Korth M, Opitz A. In: Erste klinische Erfahrungen in der Langzeitsedierung mit Isofluran. Opitz A, editor. Braunschweig: Bethel-Verlag; 1989. Methoden der Analgosedierung in der Intensivmedizin; pp. 139–146.
    1. Yates DW, Hughes JA. Isoflurane and long-term sedation. Anaesthesia. 1993;48:267–268.
    1. Röhm KD, Mengistu A, Boldt J, Mayer J, Beck G, Piper SN. Renal integrity in sevoflurane sedation in the intensive care unit with the anesthetic-conserving device: a comparison with intravenous propofol sedation. Anesth Analg. 2009;Suppl 6:1848–1854.
    1. Sackey PV, Martling CR, Granath F, Radell PJ. Prolonged isoflurane sedation of intensive care unit patients with the Anesthetic Conserving Device. Crit Care Med. 2004;32:2241–2246.
    1. Breen D, Karabinis A, Malbrain M, Morais R, Albrecht S, Jarnvig IL, Parkinson P, Kirkham AJ. Decreased duration of mechanical ventilation when comparing analgesia-based sedation using remifentanil with standard hypnotic-based sedation for up to 10 days in intensive care unit patients: a randomized trial [ISRCTN47583497] Crit Care. 2005;Suppl 3:R200–R210.
    1. Soukup J, Schärff K, Kubosch K, Pohl C, Bomplitz M, Kompardt J. State of the art: sedation concepts with volatile anesthetics in critically Ill patients. J Crit Care. 2009;Suppl 4:535–544.
    1. Mesnil M, Capdevila X, Bringuier S, Trine PO, Falquet Y, Charbit J, Roustan JP, Chanques G, Jaber S. Long-term sedation in intensive care unit: a randomized comparison between inhaled sevoflurane and intravenous propofol or midazolam. Intensive Care Med. 2011;Suppl 6:933–941.
    1. Stuttmann R, Pillukat T, Müller-Gorges M, Knüttgen D, Doehn M. In: Sedierung mit Isofluran unter pulmonalen und hämodynamischen Aspekten. Opitz A, editor. Braunschweig: Bethel-Verlag; 1989. Methoden der Analgosedierung auf der Intensivstation; pp. 139–146.
    1. Tanigami H, Yahagi N, Kumon K, Watanabe Y, Haruna M, Matsui J, Hayashi H. Long-term sedation with isoflurane in postoperative intensive care in cardiac surgery. Artif Organs. 1997;Suppl 1:21–23.
    1. Meiser A, Laubenthal H. Inhalational anaesthetics in the ICU: theory and practice of inhalational sedation in the ICU, economics, risk-benefit. Best Pract Res Clin Anaesthesiol. 2005;Suppl 3:523–538.
    1. Meiser A, Bellgardt M, Vogelsang H, Sirtl C, Weber T. Functioning of the anaesthetic conserving device: aspects to consider for use in inhalational sedation. Anaesthesist. 2010;Suppl 11:1029–1040.
    1. Perhag L, Reinstrup P, Thomasson R, Werner O. The Reflector: a new method for saving anaesthetic vapours. Br J Anaesth. 2000;Suppl 3:482–486.
    1. Thomasson R, Luttropp H, Werner O. A reflection filter for isoflurane and other anaesthetic vapours. Eur J Anaesthesiol. 1989;6:89–94.
    1. Muellejans B, Matthey T, Scholpp J, Schill M. Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: a randomized, open-label, pharmacoeconomic trial. Crit Care. 2006;Suppl 3:R91.
    1. European Medicines A. ICH Harmonised Tripartite Guideline E6: Note for Guidance on Good Clinical Practice (PMP/ICH/135/95) London: European Medicines Agency; 2002.
    1. Bundesdatenschutzgesetz (BDSG) vom 20. Dezember 1990 (BGBl. I S. 2954) neugefasst durch Bekanntmachung vom 14. Januar 2003 (BGBl. I S. 66), zuletzt geändert durch Gesetz vom 29.07.2009 (BGBl. I, S. 2254), durch Artikel 5 des Gesetzes vom 29.07. 2009. BGBl. I, S. 2355 [2384] und durch Gesetz vom 14.08.2009 (Federal Law Gazette I, S. 2814.
    1. Medicinal Products Act. in the version published on 12 December 2005 (Federal Law Gazette [BGBl.]) Part I p. 3394, last amended by Article 1 of the Ordinance of 28 September 2009. Federal Law Gazette I p. 3172.
    1. Kehl F, Smul TM, Lange M, Redel A, Roewer N. Organprotektion durch volatile Anästhetika. Anästhesiologie und Intensivmedizin. 2004;11:491–507.
    1. Röhm KD, Wolf MW, Schöllhorn T, Schellhaass A, Boldt J, Piper SN. Short-term sevoflurane sedation using the Anaesthetic Conserving Device after cardiothoracic surgery. Intensive Care Med. 2008;Suppl 9:1683–1689.
    1. Meiser A, Sirtl C, Bellgardt M, Lohmann S, Garthoff A, Kaiser J, Hügler P, Laubenthal HJ. Desflurane compared with propofol for postoperative sedation in the intensive care unit. Br J Anaesth. 2003;Suppl 3:273–280.
    1. Migliari M, Bellani G, Rona R, Isgrò S, Vergnano B, Mauri T, Patroniti N, Pesenti A, Foti G. Short-term evaluation of sedation with sevoflurane administered by the anesthetic conserving device in critically ill patients. Intensive Care Med. 2009;Suppl 7:1240–1246.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel